New Form Capital — 2019 Investments

1 investments dated 2019 · listed companies and verified rows first · show all

Cellibrecellibre.com in 𝕏Apr 2019

Cellibre engineers biological manufacturing by programming cells to produce industrial products through fermentation rather than traditional chemical synthesis.

Advanced ManufacturingBiotechDeep TechFoodTechHealthtechSan Diego, US

Ben Chiarelli(CEO)Scott Zingheim(COO + CFO)in Spiros Kambourakis(CTO)inNicky Caiazza(Executive Officer, Director)

Co-investorsAlumni Ventures Beresford Ventures Dellin Investments Delta Emerald Ventures JourneyOne Ventures Merida Capital Holdings +1 more

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.